MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories
Claire Bocciarelli, Charline Caumont, Laura Samaison, Mélanie Cariou, Aude Aline-Fardin, Laurent Doucet, Jean Roudié, Benoît Terris, Jean‐Philippe Merlio, Pascale Marcorelles, David Cappellen, Arnaud Uguen
Topics & Concepts
KRASMLH1Neuroblastoma RAS viral oncogene homologROS1ImmunohistochemistryCancer researchAnaplastic lymphoma kinaseMedicineColorectal cancerBiologyInternal medicinePathologyOncologyCancerAdenocarcinomaLung cancerDNA mismatch repairMalignant pleural effusionColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancerCancer Genomics and Diagnostics